ID CP21A_BOVIN Reviewed; 496 AA. AC P00191; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1990, sequence version 2. DT 02-SEP-2026, entry version 164. DE RecName: Full=Steroid 21-hydroxylase {ECO:0000303|PubMed:25855791}; DE EC=1.14.14.16 {ECO:0000269|PubMed:22262854, ECO:0000269|PubMed:25855791}; DE AltName: Full=21-OHase; DE AltName: Full=Cytochrome P-450c21; DE AltName: Full=Cytochrome P450 21; DE AltName: Full=Cytochrome P450 XXI; DE AltName: Full=Cytochrome P450-C21; GN Name=CYP21; Synonyms=CYP21A1, CYP21A2; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=3487086; DOI=10.1073/pnas.83.12.4243; RA Chung B., Matteson K.J., Miller W.L.; RT "Structure of a bovine gene for P-450c21 (steroid 21-hydroxylase) defines a RT novel cytochrome P-450 gene family."; RL Proc. Natl. Acad. Sci. U.S.A. 83:4243-4247(1986). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=3005319; DOI=10.1016/s0021-9258(17)35630-2; RA Yoshioka H., Morohashi K., Sogawa K., Yamane M., Kominami S., Takemori S., RA Okada Y., Omura T., Fujii-Kuriyama Y.; RT "Structural analysis of cloned cDNA for mRNA of microsomal cytochrome P- RT 450(C21) which catalyzes steroid 21-hydroxylation in bovine adrenal RT cortex."; RL J. Biol. Chem. 261:4106-4109(1986). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 121-496. RX PubMed=2424492; DOI=10.1021/bi00358a016; RA John M.E., Okamura T., Dee A., Adler B., John M.C., White P.C., RA Simpson E.R., Waterman M.R.; RT "Bovine steroid 21-hydroxylase: regulation of biosynthesis."; RL Biochemistry 25:2846-2853(1986). RN [4] RP PROTEIN SEQUENCE OF 1-15. RX PubMed=6654880; RA Ogishima T., Okada Y., Kominami S., Takemori S., Omura T.; RT "Partial amino acid sequences of two mitochondrial and two microsomal RT cytochrome P-450's from adrenal cortex."; RL J. Biochem. 94:1711-1714(1983). RN [5] RP FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=25855791; DOI=10.1074/jbc.m115.646307; RA Pallan P.S., Wang C., Lei L., Yoshimoto F.K., Auchus R.J., Waterman M.R., RA Guengerich F.P., Egli M.; RT "Human Cytochrome P450 21A2, the major steroid 21-hydroxylase: structure of RT the enzyme-progesterone substrate complex and rate-limiting c-h bond RT cleavage."; RL J. Biol. Chem. 290:13128-13143(2015). RN [6] {ECO:0007744|PDB:3QZ1} RP X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) IN COMPLEX WITH HEME AND RP 17-HYDROXYPROGESTERONE, FUNCTION, COFACTOR, AND CATALYTIC ACTIVITY. RX PubMed=22262854; DOI=10.1074/jbc.m111.323501; RA Zhao B., Lei L., Kagawa N., Sundaramoorthy M., Banerjee S., Nagy L.D., RA Guengerich F.P., Waterman M.R.; RT "Three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 RT 21A2) with two substrates reveals locations of disease-associated RT variants."; RL J. Biol. Chem. 287:10613-10622(2012). CC -!- FUNCTION: A cytochrome P450 monooxygenase that plays a major role in CC adrenal steroidogenesis. Catalyzes the hydroxylation at C-21 of CC progesterone and 17alpha-hydroxyprogesterone to respectively form 11- CC deoxycorticosterone and 11-deoxycortisol, intermediate metabolites in CC the biosynthetic pathway of mineralocorticoids and glucocorticoids CC (PubMed:22262854, PubMed:25855791). Mechanistically, uses molecular CC oxygen inserting one oxygen atom into a substrate, and reducing the CC second into a water molecule, with two electrons provided by NADPH via CC cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) CC (PubMed:22262854, PubMed:25855791). {ECO:0000269|PubMed:22262854, CC ECO:0000269|PubMed:25855791}. CC -!- CATALYTIC ACTIVITY: CC Reaction=progesterone + reduced [NADPH--hemoprotein reductase] + O2 = CC 21-hydroxyprogesterone + oxidized [NADPH--hemoprotein reductase] + CC H2O + H(+); Xref=Rhea:RHEA:50304, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:16973, ChEBI:CHEBI:17026, ChEBI:CHEBI:57618, CC ChEBI:CHEBI:58210; EC=1.14.14.16; CC Evidence={ECO:0000269|PubMed:22262854, ECO:0000269|PubMed:25855791}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50305; CC Evidence={ECO:0000305|PubMed:22262854, ECO:0000305|PubMed:25855791}; CC -!- CATALYTIC ACTIVITY: CC Reaction=17alpha-hydroxyprogesterone + reduced [NADPH--hemoprotein CC reductase] + O2 = 11-deoxycortisol + oxidized [NADPH--hemoprotein CC reductase] + H2O + H(+); Xref=Rhea:RHEA:50308, Rhea:RHEA-COMP:11964, CC Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:15379, ChEBI:CHEBI:17252, ChEBI:CHEBI:28324, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210; EC=1.14.14.16; CC Evidence={ECO:0000269|PubMed:22262854, ECO:0000269|PubMed:25855791}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50309; CC Evidence={ECO:0000305|PubMed:22262854, ECO:0000305|PubMed:25855791}; CC -!- COFACTOR: CC Name=heme b; Xref=ChEBI:CHEBI:60344; CC Evidence={ECO:0000269|PubMed:22262854}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=0.5 uM for progesterone {ECO:0000269|PubMed:25855791}; CC KM=0.44 uM for 17alpha-hydroxyprogesterone CC {ECO:0000269|PubMed:25855791}; CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000250|UniProtKB:P08686}; Peripheral membrane protein CC {ECO:0000250|UniProtKB:P08686}. Microsome membrane CC {ECO:0000250|UniProtKB:P08686}; Peripheral membrane protein CC {ECO:0000250|UniProtKB:P08686}. CC -!- DOMAIN: The leucine-rich hydrophobic amino acid N-terminal region CC probably helps to anchor the protein to the microsomal membrane. CC {ECO:0000250|UniProtKB:P08686}. CC -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M11267; AAA83247.1; -; Genomic_DNA. DR EMBL; M12918; AAA30487.1; -; mRNA. DR EMBL; K01333; AAA30486.1; -; mRNA. DR PIR; A27555; O4BOC2. DR RefSeq; NP_001013614.1; NM_001013596.1. DR PDB; 3QZ1; X-ray; 3.00 A; A/B/C/D=1-496. DR AlphaFoldDB; P00191; -. DR SMR; P00191; -. DR FunCoup; P00191; 2. DR STRING; 9913.ENSBTAP00000054564; -. DR SwissLipids; SLP:000001620; -. DR PaxDb; 9913-ENSBTAP00000054564; -. DR Ensembl; ENSBTAT00000063123.2; ENSBTAP00000054564.2; ENSBTAG00000047039.3. DR Ensembl; ENSBTAT00085077966; ENSBTAP00085021425; ENSBTAG00085014754. DR Ensembl; ENSBTAT00090060090; ENSBTAP00090032358; ENSBTAG00090028470. DR GeneID; 281741; -. DR KEGG; bta:281741; -. DR CTD; 1589; -. DR VEuPathDB; HostDB:ENSBTAG00000047039; -. DR eggNOG; KOG0156; Eukaryota. DR GeneTree; ENSGT00940000158338; -. DR InParanoid; P00191; -. DR OMA; RICVHEM; -. DR OrthoDB; 2789670at2759; -. DR BRENDA; 1.14.14.16; 908. DR Reactome; R-BTA-193993; Mineralocorticoid biosynthesis. DR Reactome; R-BTA-194002; Glucocorticoid biosynthesis. DR Reactome; R-BTA-211976; Endogenous sterols. DR SABIO-RK; P00191; -. DR EvolutionaryTrace; P00191; -. DR Proteomes; UP000009136; Chromosome 23. DR Bgee; ENSBTAG00000047039; Expressed in ureter and 91 other cell types or tissues. DR ExpressionAtlas; P00191; baseline. DR GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB. DR GO; GO:0103069; F:17-hydroxyprogesterone 21-hydroxylase activity; IDA:UniProtKB. DR GO; GO:0020037; F:heme binding; ISS:UniProtKB. DR GO; GO:0005506; F:iron ion binding; IEA:InterPro. DR GO; GO:0106309; F:progesterone 21-hydroxylase activity; IDA:UniProtKB. DR GO; GO:0004509; F:steroid 21-monooxygenase activity; IBA:GO_Central. DR GO; GO:0008395; F:steroid hydroxylase activity; ISS:UniProtKB. DR GO; GO:0006704; P:glucocorticoid biosynthetic process; IBA:GO_Central. DR GO; GO:0006694; P:steroid biosynthetic process; IDA:UniProtKB. DR GO; GO:0008202; P:steroid metabolic process; ISS:UniProtKB. DR CDD; cd20674; CYP21; 1. DR FunFam; 1.10.630.10:FF:000049; steroid 21-hydroxylase isoform X1; 1. DR Gene3D; 1.10.630.10; Cytochrome P450; 1. DR InterPro; IPR001128; Cyt_P450. DR InterPro; IPR017972; Cyt_P450_CS. DR InterPro; IPR002401; Cyt_P450_E_grp-I. DR InterPro; IPR036396; Cyt_P450_sf. DR PANTHER; PTHR24289; STEROID 17-ALPHA-HYDROXYLASE/17,20 LYASE; 1. DR PANTHER; PTHR24289:SF17; STEROID 21-HYDROXYLASE ISOFORM X1; 1. DR Pfam; PF00067; p450; 1. DR PRINTS; PR00463; EP450I. DR PRINTS; PR00385; P450. DR SUPFAM; SSF48264; Cytochrome P450; 1. DR PROSITE; PS00086; CYTOCHROME_P450; 1. DR PDBsum; 3QZ1; -. PE 1: Evidence at protein level; KW 3D-structure; Direct protein sequencing; Endoplasmic reticulum; Heme; Iron; KW Lipid metabolism; Lipid-binding; Membrane; Metal-binding; Microsome; KW Monooxygenase; Oxidoreductase; Reference proteome; Steroid-binding; KW Steroidogenesis. FT CHAIN 1..496 FT /note="Steroid 21-hydroxylase" FT /id="PRO_0000051974" FT BINDING 109 FT /ligand="heme b" FT /ligand_id="ChEBI:CHEBI:60344" FT /evidence="ECO:0000269|PubMed:22262854, FT ECO:0007744|PDB:3QZ1" FT BINDING 232 FT /ligand="17alpha-hydroxyprogesterone" FT /ligand_id="ChEBI:CHEBI:17252" FT /evidence="ECO:0000269|PubMed:22262854, FT ECO:0007744|PDB:3QZ1" FT BINDING 232 FT /ligand="progesterone" FT /ligand_id="ChEBI:CHEBI:17026" FT /evidence="ECO:0000250|UniProtKB:P08686" FT BINDING 364 FT /ligand="heme b" FT /ligand_id="ChEBI:CHEBI:60344" FT /evidence="ECO:0000269|PubMed:22262854, FT ECO:0007744|PDB:3QZ1" FT BINDING 425 FT /ligand="heme b" FT /ligand_id="ChEBI:CHEBI:60344" FT /evidence="ECO:0000269|PubMed:22262854, FT ECO:0007744|PDB:3QZ1" FT BINDING 427 FT /ligand="heme b" FT /ligand_id="ChEBI:CHEBI:60344" FT /ligand_part="Fe" FT /ligand_part_id="ChEBI:CHEBI:18248" FT /note="axial binding residue" FT /evidence="ECO:0000269|PubMed:22262854, FT ECO:0007744|PDB:3QZ1" FT CONFLICT 13 FT /note="L -> K (in Ref. 4; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 14 FT /note="A -> S (in Ref. 2; AAA30487)" FT /evidence="ECO:0000305" FT CONFLICT 401 FT /note="H -> Y (in Ref. 2; AAA30487)" FT /evidence="ECO:0000305" FT CONFLICT 431 FT /note="S -> C (in Ref. 3; AAA30486)" FT /evidence="ECO:0000305" FT STRAND 41..43 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 45..51 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 52..54 FT /evidence="ECO:0007829|PDB:3QZ1" FT STRAND 58..62 FT /evidence="ECO:0007829|PDB:3QZ1" FT STRAND 64..67 FT /evidence="ECO:0007829|PDB:3QZ1" FT STRAND 69..72 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 80..84 FT /evidence="ECO:0007829|PDB:3QZ1" FT TURN 96..100 FT /evidence="ECO:0007829|PDB:3QZ1" FT STRAND 108..111 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 115..129 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 136..152 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 160..165 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 167..172 FT /evidence="ECO:0007829|PDB:3QZ1" FT TURN 173..176 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 183..194 FT /evidence="ECO:0007829|PDB:3QZ1" FT TURN 195..200 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 203..210 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 212..214 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 220..245 FT /evidence="ECO:0007829|PDB:3QZ1" FT STRAND 253..255 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 256..259 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 278..308 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 310..324 FT /evidence="ECO:0007829|PDB:3QZ1" FT STRAND 326..331 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 337..339 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 342..354 FT /evidence="ECO:0007829|PDB:3QZ1" FT STRAND 357..360 FT /evidence="ECO:0007829|PDB:3QZ1" FT STRAND 373..377 FT /evidence="ECO:0007829|PDB:3QZ1" FT STRAND 382..385 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 387..390 FT /evidence="ECO:0007829|PDB:3QZ1" FT TURN 394..396 FT /evidence="ECO:0007829|PDB:3QZ1" FT STRAND 397..399 FT /evidence="ECO:0007829|PDB:3QZ1" FT STRAND 410..412 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 414..416 FT /evidence="ECO:0007829|PDB:3QZ1" FT STRAND 423..426 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 430..447 FT /evidence="ECO:0007829|PDB:3QZ1" FT HELIX 457..459 FT /evidence="ECO:0007829|PDB:3QZ1" SQ SEQUENCE 496 AA; 56077 MW; 2E87C829A7E66B31 CRC64; MVLAGLLLLL TLLAGAHLLW GRWKLRNLHL PPLVPGFLHL LQPNLPIHLL SLTQKLGPVY RLRLGLQEVV VLNSKRTIEE AMIRKWVDFA GRPQIPSYKL VSQRCQDISL GDYSLLWKAH KKLTRSALLL GTRSSMEPWV DQLTQEFCER MRVQAGAPVT IQKEFSLLTC SIICYLTFGN KEDTLVHAFH DCVQDLMKTW DHWSIQILDM VPFLRFFPNP GLWRLKQAIE NRDHMVEKQL TRHKESMVAG QWRDMTDYML QGVGRQRVEE GPGQLLEGHV HMSVVDLFIG GTETTASTLS WAVAFLLHHP EIQRRLQEEL DRELGPGASC SRVTYKDRAR LPLLNATIAE VLRLRPVVPL ALPHRTTRPS SIFGYDIPEG MVVIPNLQGA HLDETVWEQP HEFRPDRFLE PGANPSALAF GCGARVCLGE SLARLELFVV LLRLLQAFTL LPPPVGALPS LQPDPYCGVN LKVQPFQVRL QPRGVEAGAW ESASAQ //